Pfizer, Inc. (NYSE:PFE) will be discussing 2Q20 financial results with the investment community.on 28th July 2020 at 10:00 AM eastern time.
Those interested in listening to the conference call live via the Internet can visit www.pfizer.com
Earnings Expectation
Pfizer, Inc. is set to announce second quarter earning results on Tuesday 28th July 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, PFE to report 2Q20 income of $ 0.66 per share. For the full year, analysts anticipate top line of $ 49142.30 million, while looking forward to income of $ 2.88 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 48,500.00 million ~ $ 50,500.00 million, where as bottomline are predicted in a range of $ 2.82 ~ $ 2.92 per share
Click Here For More Historical Outlooks Of Pfizer, Inc.
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands.
